Clinical Trial Update: Neonatal Phase 1 Valacyclovir Study [Phase 1]

View source ↗

Summary

This clinical trial update reports the completed Phase 1 neonatal study of valacyclovir for herpes simplex infection, sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Simplex | Phase 1 | Status: COMPLETED